Daptomycin in treatment of Gram-positive infections in children with hematological disorders

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents

BACKGROUND This subgroup analysis of the European Cubicin Outcomes Registry Experience evaluated the safety and effectiveness of daptomycin in children and adolescent patients (<18 years). METHODS Clinical outcomes at the end of therapy were assessed as success (cured or improved), failure or nonevaluable. Safety was assessed for up to 30 days post treatment. RESULTS Eighty-one children and...

Development of daptomycin for gram-positive infections.

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

The reported incidence of deep sternal wound infection (DSWI) after cardiac surgery is 0.4-5% with Staphylococcus aureus being the most common pathogen isolated from infected wound sternotomies and bacteraemic blood cultures. This infection is associated with a higher morbidity and mortality than other known aetiologies. Little is reported about the optimal antibiotic management. The aim of the...

"موارد طحال برداری در بیماریهای خونی"splenectomy in hematological disorders" "

چکیده ندارد.

Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections.

The injectable agent daptomycin, when prescribed according to approved guidelines, can be a welcome option for treating some multiresistant, gram-positive infections that have become increasingly prevalent.